Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Flanagan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|March 17, 2020
Predictive Immune Modeling of Solid TumorsNatalie A LaFranzo, Kevin C Flanagan, Danielle Quintanilha
The Journal of Biological Chemistry|August 3, 2017
p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cellsAndrew Nickless, Abigael Cheruiyot, Kevin C Flanagan, et al.
Oncotarget|February 9, 2018
c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factorsKevin C Flanagan, Elise Alspach, Ermira Pazolli, et al.
Toxicology and Applied Pharmacology|November 13, 2010
Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated miceJames P Luyendyk, Kevin C Flanagan, C David Williams, et al.
BMC Cancer|January 8, 2025
Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinomaJeffrey Hiken, Jon Earls, Kevin C Flanagan, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Analytical Performance of an Immunoprofiling Assay Based on RNA ModelsIan Schillebeeckx, Jon R Armstrong, Jason T Forys, et al.
Scientific Reports|January 26, 2022
T cell subtype profiling measures exhaustion and predicts anti-PD-1 responseIan Schillebeeckx, Jon Earls, Kevin C Flanagan, et al.
Cancer Discovery|March 28, 2014
p38MAPK plays a crucial role in stromal-mediated tumorigenesisElise Alspach, Kevin C Flanagan, Xianmin Luo, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|March 17, 2020
Predictive Immune Modeling of Solid TumorsNatalie A LaFranzo, Kevin C Flanagan, Danielle Quintanilha
The Journal of Biological Chemistry|August 3, 2017
p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cellsAndrew Nickless, Abigael Cheruiyot, Kevin C Flanagan, et al.
Oncotarget|February 9, 2018
c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factorsKevin C Flanagan, Elise Alspach, Ermira Pazolli, et al.
Toxicology and Applied Pharmacology|November 13, 2010
Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated miceJames P Luyendyk, Kevin C Flanagan, C David Williams, et al.
BMC Cancer|January 8, 2025
Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinomaJeffrey Hiken, Jon Earls, Kevin C Flanagan, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Analytical Performance of an Immunoprofiling Assay Based on RNA ModelsIan Schillebeeckx, Jon R Armstrong, Jason T Forys, et al.
Scientific Reports|January 26, 2022
T cell subtype profiling measures exhaustion and predicts anti-PD-1 responseIan Schillebeeckx, Jon Earls, Kevin C Flanagan, et al.
Cancer Discovery|March 28, 2014
p38MAPK plays a crucial role in stromal-mediated tumorigenesisElise Alspach, Kevin C Flanagan, Xianmin Luo, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Pageof 2